Patient-derived Models: A Promising Frontier in Testing the Efficacy of Drugs for Bladder Cancer. Plage H, Dressler FF, Fendler A. Eur Urol 2024 Aug 25:S0302-2838(24)02556-9. doi: 10.1016/j.eururo.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Plage H, Dressler FF, Fendler A. Patient-derived Models: A Promising Frontier in Testing the Efficacy of Drugs for Bladder Cancer. Eur Urol 2024 Aug 25:S0302-2838(24)02556-9. doi: 10.1016/j.eururo.2024.
PMID: 39183091